Stock Comparison
ARGX vs GMAB
argenx NV ADR and Genmab AS side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$16.04B
P/E (TTM)
39.4
19.8
Forward P/E
34.0
15.6
Price/Sales
11.7
4.1
Price/Book
7.5
2.8
EV/EBITDA
33.9
15.3
Dividend Yield
—
—
Profitability
Net Margin
31.40%
21.00%
Operating Margin
30.00%
25.10%
Return on Equity
20.20%
15.00%
Return on Assets
8.86%
8.48%
Growth (YoY)
Revenue Growth
62.60%
25.30%
Earnings Growth
114.00%
-72.80%
Price & Risk
Beta
-0.0
0.7
52-Week High
$934.62
$35.43
52-Week Low
$510.06
$20.23
Analyst Target
$1,041.14
$36.82
Compare ARGX and GMAB your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.